康复期COVID-19患者双阴后PET/CT仍见肺部及肺外炎症
一项前瞻性研究对7例2020年2月重症COVID-19康复期、连续两次RT-PCR阴性的患者行[18F]FDG PET/CT,并与年龄性别匹配对照组比较。结果显示所有患者仍有残余肺部病灶,且肺部SUVmax、SUVavg、CTmax、CTavg均显著高于对照组(均p<0.01);纵隔淋巴结和肝脏SUVmax、SUVavg及脾脏SUVmax也显著高于对照组(均p<0.05);脾脏SUVmax、SUVavg与血液淋巴细胞计数显著相关。结论提示双阴后肺部及肺外仍存在显著炎症。
要点
- 重症COVID-19康复期双阴患者肺部残余病灶代谢与CT指标均高于对照。
- 纵隔淋巴结、肝脏和脾脏也显示代谢增高,提示肺外炎症持续。
- 脾脏SUVmax和SUVavg与淋巴细胞计数显著相关。
核心结论
- 重症COVID-19康复期患者连续两次RT-PCR阴性后,肺部、纵隔淋巴结、脾脏和肝脏仍存在显著炎症。
研究设计与样本
- 前瞻性研究纳入7例2020年2月重症COVID-19康复期患者,PET/CT前均已连续两次SARS-CoV-2核酸RT-PCR阴性。
- 将COVID-19患者PET/CT图像与年龄、性别匹配的对照组比较。
主要发现
- 所有患者均存在残余肺部病灶,SUVmax、SUVavg、CTmax、CTavg均显著高于对照组(均p<0.01)。
- 纵隔淋巴结和肝脏的SUVmax、SUVavg显著高于对照组(均p<0.05)。
- 脾脏SUVmax显著高于对照组(p<0.05)。
- 脾脏SUVmax(r2=0.863,p=0.003)和SUVavg(r2=0.797,p=0.007)与血液淋巴细胞计数显著相关。
- 7例患者中5例(71.4%)血液淋巴细胞计数低于正常范围。
临床怎么用
- 对重症COVID-19康复期患者,即使RT-PCR连续阴性,PET/CT仍可显示肺部及肺外炎症。
局限性
- 样本量仅7例,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in an ongoing global pandemic of coronavirus disease 2019 (COVID-19). The challenges associated with imaging infected patients have resulted, to date, in a paucity of metabolic imaging studies of patients with severe COVID-19 infection. Furthermore, it remains unclear if any abnormal metabolic events are taking place in patients who have recovered from COVID-19. PURPOSE: To use [18F] fluorodeoxyglucose ([18F] FDG) positron emission tomography/computed tomography (PET/CT) to measure metabolic activity in inflamed organs of patients convalescing post severe COVID-19 infection. MATERIALS AND METHODS: A prospective study was performed in seven convalescing patients who were recovering from severe COVID-19 infection in February 2020. Prior to [18F] FDG PET/CT, all patients had received two consecutive negative results of real-time reverse transcriptase polymerase chain reaction (RT-PCR) for SARS-CoV-2 nucleic acid. Clinical intake including symptoms, treatment, laboratory test results, and follow-up was performed. The PET/CT images of COVID-19 patients were compared to a control group of patients that were matched for age and sex. RESULTS: Residual pulmonary lesions were present in all patients and maximum standard uptake value (SUVmax), average standard uptake value (SUVavg), maximum CT intensity (CTmax), and average CT intensity (CTavg) were all significantly greater than in the control group (p < 0.01 for all). In addition, SUVmax and SUVavg were significantly greater in the mediastinal lymph node and liver, and SUVmax was significantly greater in the spleen, of COVID-19 patients compared with controls (p < 0.05 for all). For the spleen, SUVmax (r2 = 0.863, p = 0.003) and SUVavg (r2 = 0.797, p = 0.007) were significantly correlated with blood lymphocyte count, and which was below the normal range in five of the seven (71.4%) patients convalescing post severe COVID-19 infection. CONCLUSION: [18F] FDG PET/CT quantitative analysis has shown that significant inflammation remained in lungs, mediastinal lymph nodes, spleen, and liver after two consecutive negative RT-PCR tests in patients convalescing post severe COVID-19 infection.
引用
- Bai Y, Xu J, Chen L, et al. Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus. Eur J Nucl Med Mol Imaging. 2021. PMID: 33420914. doi:10.1007/s00259-020-05083-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。